MED19 抗体
Quick Overview for MED19 抗体 (ABIN7116124)
抗原
See all MED19 抗体适用
宿主
克隆类型
标记
应用范围
-
-
原理
- MED19 antibody
-
纯化方法
- Immunogen affinity purified
-
纯度
- ≥95 % as determined by SDS-PAGE
-
免疫原
- mediator complex subunit 19
-
亚型
- IgG
-
-
-
-
应用备注
- WB: 1:500-1:2000, IHC: 1:20-1:200
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- Avoid repeated freeze / thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- -20°C for 12 months
-
有效期
- 12 months
-
-
- MED19 (Mediator Complex Subunit 19 (MED19))
-
别名
- MED19
-
背景
-
Synonyms: Mediator of RNA polymerase II transcription subunit 19|Lung cancer metastasis-related protein 1|Mediator complex subunit 19|MED19|LCMR1
Background: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors.
-
分子量
- 31 kDa
-
基因ID
- 219541
-
UniProt
- A0JLT2
-
途径
- Regulation of Lipid Metabolism by PPARalpha
抗原
-